ADAM9 Is Involved in Pathological Retinal Neovascularization
Authors:
- 1 May 2009
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 29 (10) , 2694-2703
Abstract
Pathological ocular neovascularization, caused by diabetic retinopathy, age-related macular degeneration, or retinopathy of prematurity, is a leading cause of blindness, yet much remains to be learned about its underlying causes. Here we used oxygen-induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV) to assess the contribution of the metalloprotease-disintegrin ADAM9 to ocular neovascularization in mice. Pathological neovascularization in both the OIR and CNV models was significantly reduced in Adam9(-/-) mice compared to wild-type controls. In addition, the level of ADAM9 expression was strongly increased in endothelial cells in pathological vascular tufts in the OIR model. Moreover, tumor growth from heterotopically injected B16F0 melanoma cells was reduced in Adam9(-/-) mice compared to controls. In cell-based assays, the overexpression of ADAM9 enhanced the ectodomain shedding of EphB4, Tie-2, Flk-1, CD40, VCAM, and VE-cadherin, so the enhanced expression of ADAM9 could potentially affect pathological neovascularization by increasing the shedding of these and other membrane proteins from endothelial cells. Finally, we provide the first evidence for the upregulation of ADAM9-dependent shedding by reactive oxygen species, which in turn are known to play a critical role in OIR. Collectively, these results suggest that ADAM9 could be an attractive target for the prevention of proliferative retinopathies, CNV, and cancer.Keywords
This publication has 30 references indexed in Scilit:
- An Adam15 amplification loop promotes vascular endothelial growth factor‐induced ocular neovascularizationThe FASEB Journal, 2008
- Angiogenesis as a therapeutic target in arthritis: learning the lessons of the colorectal cancer experienceAngiogenesis, 2007
- Combination therapy for the treatment of ocular neovascularizationAngiogenesis, 2007
- Ocular drug development - Future DirectionsAngiogenesis, 2007
- Progenitor cells and retinal angiogenesisAngiogenesis, 2007
- Reactive oxygen species mediate androgen receptor‐ and serum starvation‐elicited downstream signaling of ADAM9 expression in human prostate cancer cellsThe Prostate, 2007
- Retinopathy of prematurityAngiogenesis, 2007
- Substrate Selectivity of Epidermal Growth Factor-Receptor Ligand Sheddases and their Regulation by Phorbol Esters and Calcium InfluxMolecular Biology of the Cell, 2007
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006
- Critical Function for ADAM9 in Mouse Prostate CancerCancer Research, 2005